MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Can We Rid Uganda of the Societal Myth That Parkinson’s Disease Is Witchcraft?

    S. Klingelhofer, H. Tamale, G. Mogan (Tillamook, USA)

    Objective: Educate rural Ugandans that Parkinson’s Disease (PD) is a scientific disorder, not contagious or the result of anything mystical Background: People with PD (PWP)…
  • 2024 International Congress

    Addressing Patient Needs: Enhancing Patient-Centered Care at the Movement Disorders Center

    M. Ivancic, A. Frohlich, W. Crutchfield, H. Morita, R. Murrow, J. Rider, D. Roque, M. Sklerov, C. Testa, J. Younce, N. Browner (Chapel Hill, USA)

    Objective: To define patients’ needs and enhance educational and quality improvement initiatives at our center. Background: Patient-centered care is critical for the managing the symptoms…
  • 2024 International Congress

    Idiopathic Parkinson’s disease and Normal pressure Hydrocephalus – a tale of two sisters

    P. Vvsrk, S. Kola, R. Alugolu, R. Kandadani, R. Borgohain (Hyderabad, India)

    Objective: Idiopathic Parkinson's disease (PD) and Normal pressure hydrocephalus (NPH) can have similar clinical presentation. However, diagnostic precision is important as clinical management differs. Previous…
  • 2024 International Congress

    Dandy-Walker syndrome. A case study.

    GM. Mussagaliyeva (Almaty, Kazakhstan)

    Objective: Present a case study with rare congenital disease for further сreating a database and developing algorithms for the management of such cases in the…
  • 2024 International Congress

    Spastic Ataxia and Motorneuron disease as possible manifestations of ATP13A2 (PARK 9) variants

    G. Dalla Zanna, A. Funcis, S. Rossi, F. Santorelli, M. Sabatelli, G. Silvestri (Rome, Italy)

    Objective: To describe 5 late-onset sporadic cases carrying either biallelic or monoallelic variants in ATP13A2, showing either spastic ataxia(Spatax) or primary lateral sclerosis (PLS) as…
  • 2024 International Congress

    Investigation of the Beta Oscillations of Local Field Potential in the Subthalamic Nucleus of the Parkinsonian Minipig Model

    HC. Lin, YH. Wu, FY. Liu, MD. Ker (Hsinchu, Taiwan)

    Objective: To investigate the features of beta oscillations of the subthalamic nucleus (STN) in the Parkinsonian minipig model. Background: Deep brain stimulation (DBS) is an…
  • 2024 International Congress

    Parkinson’s disease and Myasthenia Gravis: a case report and literature review

    C. Sánchez-Rodríguez, I. Muro, E. Casas, P. Lorenzo, C. Sanabria, A. Somovilla, L. López (Madrid, Spain)

    Objective: To present a case of comorbid Parkinson’s disease(PD) and Myasthenia Gravis(MG) and review the literature about the underlying pathogenesis mechanisms and potential treatments. Background:…
  • 2024 International Congress

    Understanding Patient and Care Partner Educational Preferences in Atypical Parkinsonism

    M. Ivancic, M. Comeau, R. Mahabir, C. Malburg, J. Shurer, K. Woods, E. Zivin, CY. Lin (Chapel Hill, USA)

    Objective: To discern preferences for education and community connection among people affected by progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), or multiple system atrophy (MSA).…
  • 2024 International Congress

    Neural oscillatory dynamics in Parkinson disease and dystonia: Insights from EEG analysis

    M. Alam, A. Beck, K. Schwabe, J. Krauss (Hannover, Germany)

    Objective: Changes in total power and entropy across raw data may enable the identification of comprehensive shifts in neural dynamics that may align with clinical…
  • 2024 International Congress

    PMM2 mutation

    H. Teive, J. Duarte, LE. de Farias, S. Raskin, F. Tensini, D. Amarante (Curitiba, Brazil)

    Objective: describe glycosylation type 1A PMM2 mutation presented as motor development regression and cognitive impairment proving to be a disease that should’ve been detected precociously.…
  • « Previous Page
  • 1
  • …
  • 211
  • 212
  • 213
  • 214
  • 215
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley